CureVac NV (CVAC)
2.66
0.00 (0.00%)
USD |
NASDAQ |
Nov 25, 10:08
CureVac Profit Margin (Quarterly): 68.44% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 68.44% |
| June 30, 2024 | -502.5% |
| March 31, 2024 | -570.2% |
| December 31, 2023 | -384.0% |
| September 30, 2023 | -295.3% |
| June 30, 2023 | -889.5% |
| March 31, 2023 | -805.4% |
| December 31, 2022 | -1.10K% |
| September 30, 2022 | -424.3% |
| June 30, 2022 | -285.8% |
| March 31, 2022 | -61.93% |
| Date | Value |
|---|---|
| December 31, 2021 | -4.70% |
| September 30, 2021 | -490.9% |
| June 30, 2021 | -679.0% |
| March 31, 2021 | -1.13K% |
| December 31, 2020 | -962.5% |
| September 30, 2020 | -713.6% |
| June 30, 2020 | -29.79% |
| March 31, 2020 | -764.7% |
| December 31, 2019 | -528.0% |
| September 30, 2019 | -1.68K% |
| March 31, 2019 | -675.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.13K%
Minimum
Mar 2021
68.44%
Maximum
Sep 2024
-528.0%
Average
-515.3%
Median
Profit Margin (Quarterly) Benchmarks
| BioNTech SE | 15.91% |
| Bayer AG | -41.96% |
| Affimed NV | -9.77K% |
| InflaRx NV | -14.09K% |
| Immatics NV | -16.95% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 21.30% |
| Return on Assets | 15.24% |
| Return on Invested Capital | 21.30% |
| Gross Profit Margin (Quarterly) | 95.56% |
| Operating Margin (Quarterly) | 74.39% |
| Return on Net Operating Assets | 32.95% |